Clinical Trials on Neoplasms, Colorectal

Total 107230 results

University Hospital Heidelberg
Institut für Klinische Krebsforschung IKF GmbH am Krankenhaus Nordwest

Completed

Combined PD-1 and CCR5 Inhibition for the Treatment of Refractory Microsatellite Stable mCRC (PICCASSO)

Metastatic Colorectal Cancer | MSS

Germany
Shanghai Henlius Biotech

Active, not recruiting

A Clinical Study to Compare the Efficacy, Safety and Immunogenicity of HLX04 and Bevacizumab Combined XELOX or mFOLFOX6 in the First-line Treatment of mCRC

Metastatic Colorectal Cancer (mCRC)

China
National Cancer Institute, Naples

Completed

Intermittent or Continuous Panitumumab Plus FOLFIRI for RAS/B-RAF Wild-type Metastatic Colorectal Cancer (IMPROVE)

Colorectal Cancer Stage IV

Italy
University of Leeds
University of Nottingham; University of Sheffield; Newcastle University; University... and other collaborators

Active, not recruiting

AREG, EREG and EGFR: Response to Anti-EGFR Agents in Colorectal Cancer

Colorectal Cancer Stage IV

United Kingdom
Check-Cap Ltd.

Completed

Evaluation C-Scan System in Providing Structural Information and Polypoid Lesions in the Colon of Healthy Subjects (CRC)

Risk for Colorectal Cancer

Israel
Thomas Jefferson University

Terminated

Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA

Stage IV Colorectal Cancer

United States
University of Warmia and Mazury in Olsztyn
Provincial Specialist Hospital in Olsztyn; Ministry of Health Republic of Poland

Unknown

Mycotoxin Exposure and Dietary Habits in Colorectal Cancer Prevention and Development Among Polish Population

Colorectal Cancer, Somatic (Diagnosis)

Poland
Norgine

Completed

Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus a Sodium Picosulfate and Magnesium Salt Solution Using Day Before-Only Dosing Regimen in Adults.

Colorectal Cancer | Colorectal Carcinoma | Colon Cleansing

Netherlands, United Kingdom, Spain, Germany, Italy, Poland
Terumo Europe N.V.
Universitaire Ziekenhuizen KU Leuven; Federation Francophone de Cancerologie...

Completed

LifePearl-Iri Pharmacokinetic Study

Metastatic Colorectal Cancer | mCRC

Belgium, Germany
Sinphar Pharmaceutical Co., Ltd
Taichung Veterans General Hospital

Completed

Safety of Orectalip® (Oxaliplatin) as Adjuvant Treatment for High-risk Stage-Ⅱ Colorectal Cancer (Oxaliplatin)

Stage-Ⅱ Colorectal Cancer

Taiwan
US Oncology Research
Quintiles, Inc.

Completed

Biomarker Analysis for Patients With Metastatic Colorectal Cancer (MCC)

Colorectal Neoplasms | Advanced Metastatic Colorectal Cancer

United States
Northwestern University
Robert H. Lurie Cancer Center

Completed

Dignity Therapy in mCRC to Increase Peaceful Awareness & Impact Goals of Care Decision-Making

Stage IV Colorectal Cancer

United States
Cancer Prevention and Research Institute, Italy
Veneto Tumor Registry, Azienda Zero, Padua, Italy

Unknown

Adenoma Detection Rate With Endocuff-Assisted Colonoscopy - an Italian Trial (ITAvision)

Colorectal Neoplasms | Colorectal Cancer | Colorectal Adenoma | Colorectal Polyp

Italy
VieCuri Medical Centre

Completed

Cardiopulmonary Exercise Test Data Averaging Methods and Preoperative Risk Assessment

Colorectal Cancer | Surgery | Colorectal Neoplasms Malignant

Netherlands
Catherine H. Davis, MD

Completed

Trends and Outcomes in Laparoscopic Versus Open Surgery for Rectal Cancer (NSQIPc)

Colorectal Surgery | Colorectal Adenocarcinoma
Academic and Community Cancer Research United
National Cancer Institute (NCI)

Active, not recruiting

Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer

Metastatic Pancreatic Adenocarcinoma | Stage IV Pancreatic Cancer AJCC v6 and v7 | Stage IV Colorectal Cancer AJCC v7 | Stage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Metastatic Gastroesophageal Junction Adenocarcinoma | Metastatic Colorectal Carcinoma | Metastatic Malignant... and other conditions

United States
Wuhan Union Hospital, China

Not yet recruiting

Molecular Study and Precision Medicine for Colorectal Cancer (MSPM)

Recurrent Colorectal Carcinoma | Advanced Colorectal Carcinoma

China
Sorlandet Hospital HF
Erasmus Medical Center; South-Eastern Norway Regional Health Authority; Maria...

Completed

Water Exchange Versus Carbon Dioxide for Colonoscopy

Pain | Colorectal Cancer | Colorectal Polyps | Colorectal Adenomas

Norway, Poland
Indiana University

Completed

Endocuff Vision Colonoscopy vs. AmplifEYE Colonoscopy

Colorectal Cancer | Colorectal Adenoma | Colorectal Polyp

United States
Medstar Health Research Institute
National Committee for Quality Assurance

Not yet recruiting

Patient Navigation for Colorectal Cancer Screening (SCREEN)

Colorectal Cancer Screening

United States
Wangxia LV

Recruiting

Trifluridine/Tipiracil Combined With Cetuximab in the Treatment of Third-line and Above RAS/BRAF Wild-type mCRC

Colorectal Cancer Metastatic

China
Tianshu Liu

Not yet recruiting

A Study of SC-0191 in Subjects With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
West China Hospital

Not yet recruiting

Exploratory Study of Irinotecan Liposomes in Maintenance Therapy of Metastatic Colorectal Cancer

Metastatic Colorectal Cancer
Amgen

Not yet recruiting

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301)

Metastatic Colorectal Cancer
Digital Health Navigation Solutions, Inc
National Cancer Institute (NCI); Wake Forest University Health Sciences

Not yet recruiting

Feasibility of a Colorectal Cancer Screening Web App in Primary Care Patients

Colorectal Cancer Screening

United States
Shanghai Zhongshan Hospital
CSPC Ouyi Pharmaceutical Co., Ltd.

Recruiting

Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
West China Hospital

Recruiting

A Clinical Study of T3011 in Combination With Regorafenib in Patients With Advanced Colorectal Cancer

Advanced Colorectal Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Irinotecan, TAS-102 Plus Bevacizumab as a Second-Line Therapy in mCRC Patients

Metastatic Colorectal Cancer

China
CNGE Conseil

Recruiting

Impact of Training Patient-centered Approach on Shared Decision in Colorectal Cancer Screening (FACELE)

Colorectal Cancer Screening

France
Shanghai Kechow Pharma, Inc.

Not yet recruiting

Efficacy and Safety of Tunlametinib Plus Vemurafenib in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer

Colorectal Cancer Metastatic
M.D. Anderson Cancer Center
Eli Lilly and Company; BioMed Valley Discoveries, Inc

Recruiting

Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy

Metastatic Colorectal Cancer

United States
Sun Yat-sen University

Recruiting

Cetuximab Plus Irinotecan in Patients With NeoRAS Wild-type Metastatic Colorectal Cancer In Third-line Therapy

Metastatic Colorectal Cancer

China
University of Wisconsin, Madison
Ipsen

Recruiting

Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

United States
University Health Network, Toronto

Recruiting

Study of Hydroxychloroquine With FOLFIRI and Bevacizumab in DTP-high Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Canada
University of Colorado, Denver
National Cancer Institute (NCI)

Recruiting

Couple-Based Mindfulness Intervention for Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

United States
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Cadonilimab in Locally Advanced MSI-H/dMMR Colorectal Cancer

dMMR Colorectal Cancer

China
Wuhan Union Hospital, China

Not yet recruiting

SBRT Combined With Fruquintinib Plus PD-1/CTLA-4 Antibody for Third-line Treatment in mCRC

Metastatic Colorectal Cancer

China
Australasian Gastro-Intestinal Trials Group
Olivia Newton-John Cancer Research Institute

Recruiting

Combining Sodium Valproate With Standard-of-care EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibody Treatment in Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Australia
AUM Biosciences Pte Ltd
Merck Sharp & Dohme LLC

Recruiting

MNK Inhibitor AUM001 in Combination With Either Pembrolizumab or Irinotecan to Treat Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Australia
Huazhong University of Science and Technology

Recruiting

SBRT Sequential CapeOX Regimen Combined With Bevacizumab and Sintilimab in First-line Treatment of mCRC

Metastatic Colorectal Cancer

China
Centre Georges Francois Leclerc

Recruiting

Evaluation of Efficacy of Trifluridine/Tipiracil Plus an Anti-IL-1α True Human Antibody Versus Trifluridine/Tipiracil Plus Placebo in Metastatic Colorectal Cancer Patients After Failure of Oxaliplatin, Irinotecan, Fluoropyrimidine (TASKIN)

Metastatic Colorectal Cancer

France
UMC Utrecht
Dutch Colorectal Cancer Group

Recruiting

Radioembolization in Elderly/ Fragile Patients With mCRC (CAIRO7)

Colorectal Cancer Metastatic

Netherlands
BeyondBio Inc.

Recruiting

A Study to Evaluate Safety and Efficacy of BEY1107 in Combination With Capecitabine in Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Korea, Republic of
Henan Cancer Hospital

Recruiting

Real-World Effectiveness of Regorafenib in the Treatment of Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Fruquintinib Plus Capecitabine as Maintenance Treatment of RAS / BRAF Wild-type Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
Dominik Paul Modest

Recruiting

Trifluridine/ Tipiracil Plus Panitumumab Versus Trifluridine/ Tipiracil Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Germany
Fudan University

Recruiting

The Combination of Fruquintinib, Tislelizumab and Stereotactic Ablative Radiotherapy in Metastatic Colorectal Cancer(RIFLE)

Metastatic Colorectal Cancer

China
Stanford University

Recruiting

Outreach and Choice in Colorectal Cancer Screening

Colorectal Cancer Screening

United States
Jiangsu Cancer Institute & Hospital

Recruiting

Surufatinib Combine With Immunotherapy and Chemotherapy for Second-line Treatment in Advanced Colorectal Cancer

Advanced Colorectal Cancer

China
Hoffmann-La Roche

Recruiting

A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

Metastatic Colorectal Cancer

United States, Korea, Republic of, United Kingdom, Australia, Germany, Taiwan, Spain, Canada, Italy, Poland, Denmark, France

Clinical Trials on Neoplasms, Colorectal

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations